EW - Is Edwards Lifesciences Stock a Buy?
As the economy continues to struggle under the weight of the COVID-19 pandemic, investors have seen stock prices plummet. While some healthcare stocks directly involved in combating the virus experienced nice gains, many otherwise healthy companies saw their share prices erode over the past month.
That's been the case with Edwards Lifesciences (NYSE: EW), a leading player in the cardiovascular and artificial heart valve markets. With shares now trading at a steep discount compared to where they were at the beginning of 2020, does this make Edwards Lifesciences a potential buy for investors looking for a good deal?
Image source: Getty Images.